{"schema_version":"secwatch.filing_event.v1","accession":"0001576280-25-000276","form_type":"8-K","ticker":"GH","cik":"0001576280","company_name":"Guardant Health, Inc.","filed_at":"2025-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.801649+00:00","generated_at":"2026-05-17T01:39:13.866571+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Guardant Health Q3 revenue $265.2M (+39% YoY); raises FY2025 revenue guidance to $965-$970M","bullets":["Q3 total revenue $265.2M (+39% YoY); GAAP net loss $92.7M ($0.74/share), non-GAAP net loss $48.3M ($0.39/share).","Oncology revenue $184.4M (+31%), 74K tests (+40%); Shield screening revenue $24.1M (from $1M), 24K tests.","FY2025 revenue guidance raised to $965-$970M (from $915-$925M), ~31% YoY growth; Screening rev guidance $71-$73M.","Non-GAAP gross margin 66% (up from 63%); cash, equivalents and restricted cash $689.5M.","Shield expanded to multi-cancer detection; Guardant360 Liquid PMA submitted to FDA; new collaborations with Quest and PathGroup."],"urls":{"canonical":"https://secwatch.observer/filing/0001576280-25-000276","json":"https://secwatch.observer/filing/0001576280-25-000276.json","markdown":"https://secwatch.observer/filing/0001576280-25-000276.md","text":"https://secwatch.observer/filing/0001576280-25-000276.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576280/000157628025000276/0001576280-25-000276-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576280/000157628025000276/gh-20251029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:39:13.866571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}